title: Diagnosis of Hallervorden-Spatz disease using MRI, (123)I-beta-CIT-SPECT and (123)I-IBZM-SPECT.
authors.affiliation: Department of Neurology, University of Leipzig, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Hermann
authors.forename: M
authors.initials: M
authors.lastname: Reuter
authors.forename: H
authors.initials: H
authors.lastname: Barthel
authors.forename: J
authors.initials: J
authors.lastname: Dietrich
authors.forename: P
authors.initials: P
authors.lastname: Georgi
authors.forename: A
authors.initials: A
authors.lastname: Wagner
mesh_terms: D000293:Adolescent; D001549:Benzamides; D002648:Child; D003042:Cocaine / Q000031:analogs & derivatives; D005917:Globus Pallidus / Q000473:pathology; D006801:Humans; D007457:Iodine Radioisotopes; D008279:Magnetic Resonance Imaging; D009460:Neurologic Examination; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000175:diagnosis*; D011759:Pyrrolidines; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D001549:Benzamides; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; C069723:2beta-carbomethoxy-3beta-(4-iodophenyl)tropane; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; D003042:Cocaine